FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
+52.54%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$209M
AUM Growth
+$209M
(+43%)
Cap. Flow
+$3.81M
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
15
New
–
Increased
5
Reduced
2
Closed
5
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$26.3M |
| 2 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$6.61M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
$3.45M |
| 4 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$499K |
| 5 |
UAM
Universal American Corp
UAM
|
$45.2K |
Top Sells
| 1 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
$16.2M |
| 2 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$8.6M |
| 3 |
Ardelyx
ARDX
|
$3.75M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$1.66M |
| 5 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$1.35M |
Sector Composition
| 1 | Healthcare | 41.43% |
